Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors
Abdin, S.M.; Zaher, D.M.; Arafa, E.-S.A.; Omar, H.A. Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors. Cancers 2018, 10, 32. https://doi.org/10.3390/cancers10020032
Abdin SM, Zaher DM, Arafa E-SA, Omar HA. Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors. Cancers. 2018; 10(2):32. https://doi.org/10.3390/cancers10020032
Chicago/Turabian StyleAbdin, Shifaa M., Dana M. Zaher, El-Shaimaa A. Arafa, and Hany A. Omar. 2018. "Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors" Cancers 10, no. 2: 32. https://doi.org/10.3390/cancers10020032